Glaucoma researcher gets grant
Dean McGee Eye Institute researcher Michael H. Elliott has been named an Alcon Research Institute Young Investigator Grant recipient for 2013, joining an international group of scientists being recognized for excellence in ophthalmic research. Elliott, an assistant professor in the University of Oklahoma College of Medicine's Department of Ophthalmology, will use the award to further his research into the role of a specific molecule, caveolin-1 (CAV1), which is linked to a form of glaucoma called primary open-angle glaucoma. Glaucoma is the second-leading cause of blindness worldwide, and primary open-angle glaucoma is the most common type. Dr. Gregory Skuta, CEO of the Dean McGee Eye Institute and Edward L. Gaylord Professor and chair of the OU College of Medicine's Department of Ophthalmology, said Elliot is the institute's first researcher to receive an Alcon young investigator grant, and “another example of why the institute's researchers are among the nation's most highly regarded vision scientists.” The $50,000 Alcon Research Institute Young Investigator Award is intended to encourage and promote the early career development of clinicians and scientists entering research in vision science and ophthalmology.
Orthocare Innovations awarded
The Edison Awards has recognized Orthocare Innovations with its top award in the Science and Medicine — Assistive Device category. Oklahoma City-based Orthocare won the top award for its Magellan microprocessor foot ankle system prosthetic device. Edison Awards recognizes ideas at the forefront of new products, services, marketing, design and innovation. Magellan brings a novel approach to lower limb prosthetics by mimicking key features of the human ankle that are essential to normal gait. Magellan offers active ankle function using microprocessor computer control, combined with micro-hydraulic technology, providing people who have lost limbs with enhanced efficiency, stability and comfort. A key feature is Magellan's connectivity, linking the device to its user and the user's health care providers. This functionality, afforded by iPhone and iPad apps and Bluetooth technology, enables patients to make adjustments to the Magellan themselves, such as adaptations to account for changes in footwear. This functionality also extends to health care providers, affording access to patient performance and device diagnostics.
Continue reading this story on the...